OTC: COGZF - Cogstate Limited

Rentabilidade por seis meses: -25.93%
Setor: Healthcare

Cronograma de promoção Cogstate Limited

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments.

Mais detalhes
The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

EBITDA -0.0047
Industry Health Care Technology
P/BV 1.16
P/E 37.25
P/S 0.5359
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0311
Сайт https://www.cogstate.com
Цена ао 0.83
Число акций ао 0.17319 млрд
Alteração de preço por dia: +0.8065% (0.5952)
Alteração de preço por semana: +1.69% (0.59)
Alteração de preço por mês: -6.25% (0.64)
Alteração de preço em 3 meses: -20% (0.75)
Mudança de preço em seis meses: -25.93% (0.81)
Mudança de preço por ano: -28.57% (0.84)
Mudança de preço em 3 anos: -63.86% (1.66)
Mudança de preço em 5 anos: -34.07% (0.91)
Mudança de preço desde o início do ano: -38.78% (0.98)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 2.87 6
P/BV 3.05 5
P/E 22.88 6
EV/EBITDA 0 0
Total: 6.13

Eficiência

Nome Significado Nota
ROA, % 9.42 3
ROE, % 13.32 4
Total: 2.83

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA 0 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 25.88 4
Rentabilidade Ebitda, % -221.06 0
Rentabilidade EPS, % -382.41 0
Total: 0.8
Mais detalhes

Instituições Volume Compartilhar, %
Bard Financial Services, INC. 12500 0.01



Supervisor Cargo Pagamento Ano de nascimento
Prof. Paul Maruff BBSc (Hons), Ph.D. Founder & Chief Innovation Officer N/A
Mr. Darren Watson Chief Financial Officer 356.18k
Mr. Kenneth Billard Chief Commercial Officer 417.18k
Ms. Rachel Colite Executive VP of Clinical Trials 290.87k
Ms. Kristi Geddes General Counsel, Joint Company Secretary & Director N/A
Mr. David James Franks BEc, C.A., F Fin, J.P. Joint Company Secretary N/A 1970 (54 ano)
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Executive Director

Endereço: Australia, Melbourne. VIC, 367 Collins Street - abrir no Google Maps, abrir mapas Yandex
Site: https://www.cogstate.com